- About
- Home
- Introduction
- Statistics
- Programs
- Dignet
- Gene
- GenePair
- BioSummarAI
- Help & Docs
- Documents
- Help
- FAQs
- Links
- Acknowledge
- Disclaimer
- Contact Us
Gene Information
Gene symbol: PLAC1
Gene name: placenta-specific 1
HGNC ID: 9044
Synonyms: CT92
Related Genes
| # | Gene Symbol | Number of hits |
| 1 | FAM126A | 1 hits |
| 2 | HLA-A | 1 hits |
| 3 | MAGEA3 | 1 hits |
Related Sentences
| # | PMID | Sentence |
| 1 | 18183594 | A serological survey revealed that 3.8% (4/101) of HCC patients had anti-PLAC1 antibody response, suggesting the immunogenicity of PLAC1 in HCC patients. |
| 2 | 21710262 | Binding affinity and stability assays in T2 cells showed that two native peptides, p28 and p31, and their analogues (p28-1Y9 V, p31-1Y2L) had more potent binding activity towards HLA-A*0201 molecule. |
| 3 | 21710262 | The CTLs induced by these four peptides from the peripheral blood mononuclear cells (PBMCs) of HLA-A*02+ healthy donor could lyse MCF-7 breast cancer cells (HLA-A*0201+, PLAC1+) in vitro. |
| 4 | 23390371 | We evaluated the expression of MAGE-A3, PLAC1, GAGE, and CTAG2 in a series of colorectal cancers (CRC). |
| 5 | 23390371 | In addition, plasma antibody titers specific to MAGE-A3, PLAC1, GAGE, and CTAG2 were determined via ELISA. |
| 6 | 23390371 | Tumor expression of MAGE-A3, CTAG2, and GAGE was compared to the levels of expression in testis. |
| 7 | 23390371 | MAGE-A3 and PLAC1 may hold promise as vaccine targets for CRC. |
| 8 | 23390371 | We evaluated the expression of MAGE-A3, PLAC1, GAGE, and CTAG2 in a series of colorectal cancers (CRC). |
| 9 | 23390371 | In addition, plasma antibody titers specific to MAGE-A3, PLAC1, GAGE, and CTAG2 were determined via ELISA. |
| 10 | 23390371 | Tumor expression of MAGE-A3, CTAG2, and GAGE was compared to the levels of expression in testis. |
| 11 | 23390371 | MAGE-A3 and PLAC1 may hold promise as vaccine targets for CRC. |
| 12 | 23390371 | We evaluated the expression of MAGE-A3, PLAC1, GAGE, and CTAG2 in a series of colorectal cancers (CRC). |
| 13 | 23390371 | In addition, plasma antibody titers specific to MAGE-A3, PLAC1, GAGE, and CTAG2 were determined via ELISA. |
| 14 | 23390371 | Tumor expression of MAGE-A3, CTAG2, and GAGE was compared to the levels of expression in testis. |
| 15 | 23390371 | MAGE-A3 and PLAC1 may hold promise as vaccine targets for CRC. |